Young people who vape are more likely to have health issues or pick up other drug habits

Publicly released:
International
Photo by Sebastian Radu on Unsplash
Photo by Sebastian Radu on Unsplash

Teens and young people who vape are more likely to go on to pick up smoking, marijuana and drinking, and face higher risks of a host of health issues, according to international research. The team conducted an umbrella review - collecting previous reviews of research on the topic of young people and vaping to assess the current evidence around potential harms. Combining the results of 21 previous systematic reviews, the researchers say most found young people who vape are three times more likely to pick up smoking and were consistently more likely to start using marijuana, drinking and binge drinking alcohol. Vaping was also linked to asthma diagnoses and worsening symptoms, and the researchers say there was some evidence of links to a range of different health issues, including pneumonia, low sperm counts, migraines and poor mouth health.

Media release

From: BMJ Group

Youth vaping consistently linked to subsequent smoking, marijuana and alcohol use 

As well as heightened risks of asthma, cough, injuries and mental ill health + possibly pneumonia, bronchitis, headaches, migraines, dizziness, low sperm count, poor oral health

Vaping among teens and young people is consistently linked to subsequent smoking, marijuana and alcohol use, finds an overarching (umbrella) review of systematic reviews of the evidence, published online in the journal Tobacco Control.

And it’s associated with other harmful consequences, including heightened risks of asthma, cough, injuries and mental ill health as well as possibly pneumonia, bronchitis, headaches, migraine, dizziness/lightheadedness, low sperm count, and poor mouth health.

The findings reinforce policy measures to restrict sales and marketing of vapes to young people, conclude the researchers.

The World Health Organization (WHO) has described the rise in the prevalence of children who vape around the world as "alarming." The proportion of 15–16 year olds who vape ranges from 5.5% to 41% in WHO Europe region countries alone, note the researchers. And concerns persist about the harms of vaping in young people, in particular whether vaping leads to smoking.

Although four umbrella reviews on the topic have been published, these don’t focus exclusively on young people or do so only for a narrow set of outcomes, such as smoking initiation, they add.

To strengthen the evidence base and uncover the extent of physical and mental harms associated with vaping among young people, the researchers carried out an overarching review of existing systematic (and umbrella) reviews after scouring research databases.

The 56 reviews (52 systematic reviews and 4 umbrella reviews) included pooled data analyses and health technology assessment reports, published between 2016 and 2024, with most (47) published after 2020.

Synthesis of the data from 21 systematic reviews revealed a consistent and significant association between vaping and starting smoking, ranging from a 50% to 26-fold higher risk, and suggesting a causal relationship, say the researchers.

Most of these reviews suggested that young people who vape are about 3 times as likely to start smoking as those who don’t vape.

Pooled data analysis of the results of 5 systematic reviews showed a strong link between vaping and substance use, ranging from a near tripling to 6-fold heightened risks for marijuana, a 4.5 to more than 6-fold increased risk for alcohol, and a 4.5 to a nearly 7-fold increased risk for binge drinking.

Asthma was the most common respiratory health outcome, with consistent associations of between 20% and 36% heightened risks of being diagnosed with the condition, and a 44% heightened risk of worsening symptoms.

Synthesis of the findings from 3 systematic reviews showed associations between vaping and suicidal outcomes, and 6 others suggested associations between burn injuries or similar.

Significant associations emerged between vaping and other harmful health outcomes, including pneumonia, bronchitis, lower total sperm counts, dizziness, headaches, migraines and poor mouth health, although this evidence was largely derived from limited surveys or case series/reports, note the researchers.

They acknowledge that the quality of umbrella reviews depends on the quality of the included systematic reviews. And much of the evidence on outcomes was observational. Inferring causality therefore remains difficult, say the researchers.

“None the less, given the consistent associations we observed with increased smoking and multiple possible harms to health and wellbeing in this age group, which are consistent with possible causal effects, the evidence supports policy measures to protect young people who do not smoke from the potential risks associated with vaping,” they emphasise.

These measures include restricting the sales and marketing of vapes to young people, and curbs on advertising design features that are likely to appeal to them.

“Such efforts may form part of a wider set of measures to restrict harms, including raising the public’s and young people’s awareness of these harms, and counter-marketing to raise public and policy awareness of the marketing and strategies that e-cigarette companies have targeted at children and young people,” they add.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research BMJ Group, Web page The URL will go live after the embargo ends
Journal/
conference:
Tobacco Control
Research:Paper
Organisation/s: University of York, UK
Funder: The study is independent research carried out by the Public Health Policy Research Unit (PH-PRU), grant No PH_PRU_1217_20901, commissioned and funded by the National Institute for Health and Social Care Research (NIHR) Policy Research Programme. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care (DHSC). MP is co-investigator in the SPECTRUM consortium which is funded by the UK Prevention Research Partnership (UKPRP), a consortium of UK funders (UKRI Research Councils: Medical Research Council (MRC), Engineering and Physical Sciences Research Council (EPSRC), Economic and Social Research Council (ESRC) and Natural Environment Research Council (NERC); charities: British Heart Foundation, Cancer Research UK, Wellcome and the Health Foundation; government: Scottish Government Chief Scientist Office, Health and Care Research Wales, NIHR and Public Health Agency (NI)). SG is employed by the University of York and has worked on grants from NIH, NIHR, DHSC, MRC and Wellcome. SG has authored Cochrane Reviews and a Cochrane handbook. GH has received funding from NIHR and ESRC and, as a clinical academic, holds an honorary contract with the Office for Health Improvement and Disparities (OHID). REG has accepted funding from NIHR and MRC and accepted honoraria from WHO and the Academy of Medical Sciences. LMB and SGN are Public Health Specialty Registrars and writing in their capacity as Honorary Research Fellows at the London School of Hygiene and Tropical Medicine. SGN also has an honorary contract with the UK Health Security Agency (UKHSA).
Media Contact/s
Contact details are only visible to registered journalists.